Adicet Bio, Inc. SEC filings ACET
Adicet Bio, Inc. has 682 filings in SEC EDGAR's recent list, going back to Oct 27, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 26.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 28, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 23, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 1, 2026 | Sep 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 7, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 21, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 21, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 21, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 21, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 21, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 10-K/A | Amended annual report | May 20, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| S-8 POS | Filing | May 13, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 4 | Insider transaction | Apr 29, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Apr 28, 2026 | Apr 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 13, 2026 | — |
| 4 | Insider transaction | Apr 13, 2026 | Feb 18, 2026 |
| 3 | Initial insider ownership | Apr 13, 2026 | Feb 17, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 10, 2026 | — |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 144 | Notice of proposed sale | Apr 8, 2026 | — |
| 144 | Notice of proposed sale | Apr 7, 2026 | — |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| EFFECT | Filing | Mar 23, 2026 | — |
| CORRESP | Letter to the SEC | Mar 19, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| S-3 | Shelf registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 29, 2026 | — |
| 4 | Insider transaction | Jan 27, 2026 | Jan 24, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 24, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 24, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Dec 29, 2025 | Dec 26, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 19, 2025 | Dec 19, 2025 |
| DEF 14A | Proxy statement | Nov 17, 2025 | Dec 19, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 5, 2025 | Dec 19, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Oct 10, 2025 | Oct 8, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 10, 2025 | — |
| 8-K |
Current report
Listing notice
|
Oct 7, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 7, 2025 | Oct 7, 2025 |
| 424B5 | Prospectus supplement | Oct 7, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 7, 2025 | Oct 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| S-8 | Employee stock plan registration | Jul 25, 2025 | — |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Jul 23, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 29, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 3 | Initial insider ownership | Apr 21, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 17, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 11, 2025 | Apr 7, 2025 |
| S-8 POS | Filing | Mar 26, 2025 | — |
| 424B5 | Prospectus supplement | Mar 18, 2025 | — |
| EFFECT | Filing | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 12, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| S-3 | Shelf registration | Mar 6, 2025 | — |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 3 | Initial insider ownership | Jan 23, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 19, 2024 | Dec 19, 2024 |
| 8-K |
Current report
Agreement ended
|
Nov 27, 2024 | Nov 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 15, 2024 | Nov 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2024 | Oct 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 19, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 19, 2024 |
| 3 | Initial insider ownership | Aug 20, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 19, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 24, 2024 | Jun 24, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| 144 | Notice of proposed sale | Jun 5, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 10, 2024 | May 10, 2024 |
| DEFR14A | Filing | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Apr 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 22, 2024 | Apr 22, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Apr 12, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 22, 2024 | Mar 22, 2024 |
| 424B5 | Prospectus supplement | Mar 22, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 21, 2024 | — |
| S-8 POS | Filing | Mar 19, 2024 | — |
| S-8 | Employee stock plan registration | Mar 19, 2024 | — |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2024 | Mar 19, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 27, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 5, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 2, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jan 29, 2024 | — |
| 4 | Insider transaction | Jan 26, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 24, 2024 | Jan 22, 2024 |
| 424B5 | Prospectus supplement | Jan 24, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 23, 2024 | — |
| 424B5 | Prospectus supplement | Jan 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 19, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 16, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2023 | Nov 7, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACET (Nasdaq)
- Fiscal year ends
- December 26
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1720580
- Former names
- resTORbio, Inc. (until Aug 21, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.